top of page
Bio-medical Engineering - Cell Microarray

        Cancer metastasis and drug resistance are important malignant phenotypes of tumors that cause roughly 90% mortality in human-associated cancers. Three-dimensional (3D) tissue culture platforms that are capable of mimicking in vivo microenvironments to replicate physiological conditions are vital tools in a wide range of cellular and clinical studies. Currently therapeutic drug synergism intervened in but not limited to the treatment of cancer, metabolic, or inflammation disorders has been the crucial avenue rather than using a single effector. This regimen not only improves the therapeutic efficacy by triggering synthetic lethality in target cells, but it also minimizes the side effects by reducing doses of each drug. 

        Herein we present a novel biomimic tumor microarray platform that is inspired from Stenocara gracilipesbeetle’s bumpy back surfaces. By incorporating laser-direct writing, we can control the hydrophilic-hydrophobic interfaces with configurable features of both cultivating 3D cells and performing high-throughput drug synergy screening. 

Figure 3.jpg

Figure 1. High-throughput drug screening by the microcrater-arrayed (µCA) chips. (a) Experimental procedure of the drug screening. (b) Demonstration for the high-throughput drug screening on SK-N-DZ cells by the µCA chip. Live cells were evaluated based on the detection of chemiluminescence. Cyp: cyclophosphamide; Cis: cisplatin; Dox: doxorubicin; Onc: oncovin; Eto: etoposide. Scale bar is 170 µm, and the insert bar is 50 µm. Data represent the mean ± SD, n = 3 independent experiments.  

未命名.jpg

References

1. Ching-Te Kuo, Yu-Sheng Lai, Siang-Rong Lu, Hsinyu Lee, Hsiu-Hao Chang, “Microcrater-Arrayed Chemiluminescence Cell            Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model,” Biology, 11(1), 4, 2022. 

2. Ching-Te Kuo, Jong-Yueh Wang, Siang-Rong Lu, Yu-Sheng Lai, Hsiu-Hao Chang, Jer-Tsong Hsieh, Andrew M. Wo, Benjamin P.    C. Chen, Jen-Her Lu,  Hsinyu Lee, “A nanodroplet cell processing platform facilitating drug synergy evaluations for anti-cancer      treatments,” Scientific Reports, 9, 10120, 2019. 

bottom of page